S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q2 2026

BVF Partners

Period: Q2 2026 · Filed: 2026-08-14
View on SEC EDGAR
AUM
$3.91B
Total portfolio value
Positions
44
Reported securities
Top Holding
RVMD
14.2% $555.3M
QoQ Changes
+7 / -4
new · exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings — not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares — not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with ≥$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2026-08-14) shown is the underlying stock price movement — not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
RVMDREVOLUTION MEDICINES INC$555.3M14.20%$187.28$203.71+8.8%
14.2%
KYMRKYMERA THERAPEUTICS INC$444.0M11.35%$114.67$117.39+2.4%
11.3%
XOMAXOMA ROYALTY CORPORATION$322.7M8.25%
8.3%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$311.5M7.97%$19.47$16.47-15.4%
8.0%
GHRSGH RESEARCH PLC$232.5M5.95%$26.88$29.49+9.7%
6.0%
GPCRSTRUCTURE THERAPEUTICS INC$180.7M4.62%$53.67$54.51+1.6%
4.6%
NKTRNEKTAR THERAPEUTICS$166.9M4.27%$69.81$73.02+4.6%
4.3%
MIRMMIRUM PHARMACEUTICALS INC$123.6M3.16%$117.07$100.64-14.0%
3.2%
XNCRXENCOR INC$114.8M2.94%$16.10$23.34+45.0%
2.9%
ALKSALKERMES PLC$112.9M2.89%$52.40$49.06-6.4%
2.9%
GLUEMONTE ROSA THERAPEUTICS INC$108.0M2.76%$24.20$15.50-36.0%
2.8%
CGEMCULLINAN THERAPEUTICS INC$104.7M2.68%$18.21$20.34+11.7%
2.7%
PVLAPALVELLA THERAPEUTICS INC NE$102.8M2.63%$152.82$156.13+2.2%
2.6%
ZYMEZYMEWORKS INC$95.4M2.44%$26.14$25.12-3.9%
2.4%
KURAKURA ONCOLOGY INC$92.7M2.37%$10.97$10.86-1.0%
2.4%
IRONDISC MEDICINE INC$84.4M2.16%$73.14$78.84+7.8%
2.2%
STOKSTOKE THERAPEUTICS INC$83.4M2.13%$32.72$31.27-4.4%
2.1%
OLMAOLEMA PHARMACEUTICALS INC$66.3M1.69%$12.51$10.63-15.0%
1.7%
ANNXANNEXON INC$49.7M1.27%$5.71$5.29-7.4%
1.3%
CBIOCRESCENT BIOPHARMA INC.$49.5M1.27%$18.00$17.14-4.8%
1.3%
ACIUAC IMMUNE SA$47.2M1.21%$2.38$2.49+4.6%
1.2%
TYRATYRA BIOSCIENCES INC$47.1M1.21%$31.94$25.29-20.8%
1.2%
STROSUTRO BIOPHARMA INC$41.6M1.06%$33.20$20.48-38.3%
1.1%
IMCRIMMUNOCORE HLDGS PLC$41.1M1.05%$31.75$34.21+7.8%
1.1%
AVTXAVALO THERAPEUTICS INC$38.4M0.98%$18.48$19.59+6.0%
1.0%
FDMT4D MOLECULAR THERAPEUTICS IN$38.3M0.98%$13.30$12.19-8.3%
1.0%
QTTBQ32 BIO INC$29.9M0.77%$12.74$15.15+18.9%
0.8%
AVRANTERIS TECHNOLOGIES GLOBAL$29.6M0.76%$9.85$9.40-4.6%
0.8%
FHTXFOGHORN THERAPEUTICS INC$28.5M0.73%$4.88$6.26+28.3%
0.7%
ABSIABSCI CORPORATION$27.4M0.70%$11.59$9.18-20.8%
0.7%

Quarter-on-Quarter Activity

Q2 2026 vs. Q1 2026

New Positions (7)

TickerIssuerNotionalSince Filing
QTTBQ32 BIO INC$29.9M+18.9%
ABSIABSCI CORPORATION$27.4M-20.8%
SGMTSAGIMET BIOSCIENCES INC$19.3M
IMUXIMMUNIC INC$11.8M
RESEARCH ALLIANCE CORP III$5.3M
ENTXENTERA BIO LTD$4.3M
ENGNWENGENE THERAPEUTICS$0.3M

Exited Positions (4)

TickerIssuerNotional
CMPXCOMPASS THERAPEUTICS INC$41.1M
SEPNSEPTERNA INC$32.5M
IMUXIMMUNIC INC$8.5M
ENGNWENGENE HOLDINGS INC$2.5M

Increased (6)

TickerIssuerNotionalShares ΔSince Filing
XOMAXOMA ROYALTY CORPORATION$241.5M+193.1%
OKURONKURE THERAPEUTICS INC$6.6M+63.5%
IVVDINVIVYD INC$-0.8M+44.3%
AVTXAVALO THERAPEUTICS INC$14.0M+27.1%+6.0%
ALKSALKERMES PLC$42.2M+7.7%-6.4%
RVMDREVOLUTION MEDICINES INC$277.5M+3.8%+8.8%

Trimmed (8)

TickerIssuerNotionalShares ΔSince Filing
MIRMMIRUM PHARMACEUTICALS INC$-22.8M-33.4%-14.0%
PVLAPALVELLA THERAPEUTICS INC NE$-17.0M-30.0%+2.2%
KYMRKYMERA THERAPEUTICS INC$-14.3M-29.6%+2.4%
TYRATYRA BIOSCIENCES INC$-28.5M-25.3%-20.8%
IRONDISC MEDICINE INC$3.0M-9.3%+7.8%
NKTRNEKTAR THERAPEUTICS$-17.2M-6.6%+4.6%
GPCRSTRUCTURE THERAPEUTICS INC$14.0M-2.7%+1.6%
ZYMEZYMEWORKS INC$1.9M-2.3%-3.9%
Back to Hedge Funds